Tempo Trace
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- —0 ratings
- Paid $24.99
- Updated
- Observed
Ratings
Observed0
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived63/100Promising · low confidence
Own Tempo Trace? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made Tempo Trace? Add a “Tracked in Medical” badge to your site
About Tempo TraceObserved
Tempo Trace is a Medical app by Clear Health Media on the United States App Store. Released Oct 6, 2026; last updated Oct 6, 2026 (version 1.0). Tempo Trace costs $24.99 to download.
MRRBeam rates the success of Tempo Trace 0/100 (early stage).
How closely can you match the beat? Tempo Trace challenges you to anticipate a steady rhythm and time your movements to match. Tap the screen or clap your hands, then see how accurately and consistently your responses line up with the metronome.
- Success score
- 0/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- Clear Health Media
Loading the full report…
Tempo Trace: common questions
- What is Tempo Trace?
- Tempo Trace is a Medical app developed by Clear Health Media, available on the App Store. It was first released on Oct 6, 2026.
- How much does Tempo Trace cost?
- Tempo Trace costs $24.99 to download.
- Is Tempo Trace successful?
- MRRBeam rates the success of Tempo Trace 0/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was Tempo Trace last updated?
- Tempo Trace was last updated on Oct 6, 2026 (version 1.0).
- What are alternatives to Tempo Trace?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to Tempo Trace?
- MRRBeam's opportunity score for Tempo Trace is 63/100. A recent launch with a thin review footprint (0 reviews).